• Biotalys announces results of independent field trials in the U.S.

    Tuesday December 19th 2023

  • Mithra receives positive DSMB Opinion on DONESTA® European Phase 3 Trial

    Monday December 18th 2023

  • Belgian researchers find a crack in the wall of WHO’s top priority pathogens

    Thursday December 14th 2023

  • AstriVax awarded €3 million grant to advance therapeutic Hepatitis B vaccine

    Tuesday December 12th 2023

  • Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology

    Tuesday December 12th 2023

  • KU Leuven formally opens new research centre for innovative gene therapy

    Friday December 8th 2023

  • VUB team develops nanobody technology against liver inflammation

    Monday December 4th 2023

  • Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

    Monday December 4th 2023

  • Your news here?

  • Celyad announces management change

    Friday December 1st 2023

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023

  • Agomab appoints Angelika Jahreis as Member of the Board of Directors and Andrea Sáez as Chief Development Officer

    Wednesday November 29th 2023


Strategic Partners